mailed
on 09 Mar 2024
Last Applicant/ Owned by
873 Rue Saint-Jean, suite 200
Quebec (Quebec)
CA
G1R1R2
Serial Number
88813289 filed on 27th Feb 2020
Registration Number
N/A
Correspondent Address
Peter Kunin
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
Development of pharmaceutical preparations and medicines; pharmaceutical research and development; software as a service (SAAS) services featuring artificial intelligence software for use in the pharmaceuticals and healthcare fields, namely, for diagnostic and therapeutic use, and for data mining in the field of vaccinal pharmacologic treatment and allergy medications; platform as a service (PAAS)Read More
Medical services, namely, vaccinal pharmacologic treatment of autoimmune diseases such as psoriasis, Crohn's disease, rheumatoid arthritis, cancer, infectious diseases and allergies; health care services, namely, desensitization treatments for allergy; medical services, namely, immunotherapy in the fields of cancer, autoimmune, infectious disease and orphan diseases conditions in humans and veterinary applications; medical treatment of allergies, cancer, and auto-immune diseases destined to generate, in response to its administration in patients, the production of the patient's own antibodies
Development of pharmaceutical preparations and medicines; pharmaceutical research and development; software as a service (SAAS) services featuring artificial intelligence software for use in the pharmaceuticals and healthcare fields, namely, for diagnostic and therapeutic use, and for data mining in the field of vaccinal pharmacologic treatment and allergy medications; platform as a service (PAAS) services featuring artificial intelligence software platforms for use in the pharmaceuticals and healthcare fields, namely, for diagnostic and therapeutic use, and for data mining for use in the field of vaccinal pharmacologic treatment and allergy medications
Protein arrays for medical diagnosis purposes; Protein arrays for therapeutic use for treating cancer, allergies, autoimmune disease, infection disease, and inflammatory disease; biopharmaceuticals for treatment of cancer, allergies, autoimmune disease, infection disease
Chemicals for scientific, laboratory and medical research; chemicals for use in the manufacture of pharmaceuticals; biochemicals, namely, antibodies for scientific, laboratory and medical research; proteins for immunoassay for detection, for diagnostic purposes, for therapeutic purposes, and for treatment of cancer, allergies, autoimmune disease, infection diseases
No 88813289
No Service Mark
No 13615136UST1
Yes
Yes
No
Yes
No
No
No
No
| Status Date | Action Taken |
|---|---|
| 09th Mar 2024 | SUSPENSION INQUIRY WRITTEN |
| 09th Mar 2024 | INQUIRY TO SUSPENSION E-MAILED |
| 09th Mar 2024 | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED |
| 16th Feb 2024 | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION |
| 14th Aug 2023 | SUSPENSION LETTER WRITTEN |
| 14th Aug 2023 | LETTER OF SUSPENSION E-MAILED |
| 14th Aug 2023 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
| 29th Jun 2023 | ASSIGNED TO EXAMINER |
| 04th May 2023 | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED |
| 01st Dec 2022 | SUSPENSION INQUIRY WRITTEN |
